Established in 1948, the Henry J. Kaiser Family Foundation is an independent philanthropy dedicated to providing the best possible information and analysis on the major health issues facing the nation to policy makers, the media, and the public. It is primarily an operating foundation that develops and runs its own research and communications programs, often in partnership with outside organizations. More about the Kaiser Family Foundation.
The Kaiser Family Foundation operates four Web sites:
The Kaiser Family Foundation's main Web site provides complete access to the Foundation's reports, surveys, issue briefs, charts, and fact sheets containing in-depth analysis and the public's views on timely and critical issues such as increasing health care costs, global HIV/AIDS, racial disparities, women's health policy, the rising numbers of uninsured, Medicare reform, and how states' fiscal situations are affecting Medicaid.
Kaiser Health News (KHN), a nonprofit news organization dedicated to in depth coverage of health care policy and politics, provides coverage of health policy issues and developments at the federal and state levels, in the health care marketplace and health care delivery system. KHN also provides daily summaries of news coverage of health from across the nation, original programming from Kaiser's broadcast studio, and a broad range of commentary from contributing writers and experts. KHN provides opportunities for health care journalists to produce in-depth work and a vehicle to distribute it through collaborations with major news organizations and on its Web site.
State Health Facts Online provides up-to-date and easy-to-use health information and data on all 50 states, covering a broad range of topics including health insurance coverage and the uninsured, state legislative policies, Medicaid, Medicare, health care costs, prescription drugs, health status, and population demographics. The information can be displayed as tables or color-coded maps, and raw data may be downloaded for custom analyses.
KaiserEDU provides a wealth of information that can be used as an integral part of an academic course or as an additional source for independent research. The information, compiled from the Foundation's work and from the larger health policy community, is presented in a variety of online formats, including text, graphics, slideshows, and webcasts, in order to provide a full array of multimedia tools for different methods of teaching and learning.
Kaiser Family Foundation Headquarters
2400 Sand Hill Road
Menlo Park, CA 94025
phone: (650) 854-9400
fax: (650) 854-4800
Washington, D.C. Office/Barbara Jordan Conference Center/Broadcast Studio
1330 G Street, NW
Washington, DC 20005
phone: (202) 347-5270
fax: (202) 347-5274
2400 Sand Hill Road
Menlo Park, CA 94025
e-mail: Contact Us Page
Categories Covered:HIV in Specific Countries, HIV Prevention Methods, Substance Use and Harm Reduction for HIV, HIV Care and Services Outside the US, Finding HIV Support Groups and Services, Regional/Global Anti-HIV Efforts, HIV Treatments in Development, Nelfinavir (Viracept), HIV Education and Risk Management, Adverse Events, Comorbidities, and HIV, Pregnancy, Childbirth, and HIV, Dolutegravir (Tivicay), HIV Policy and Advocacy, Financial Issues, HIV Epidemiology, Providing Quality HIV Care, HIV Testing, HIV/AIDS Outside the U.S., Legal Issues, HIV Treatment Strategies, HIV-Related Policy Issues, HIV Prevention and Transmission, Meeting the Costs of HIV Care, HIV Care Continuum, HIV Testing, Pediatric HIV Care, Flu (Influenza), Colds, and HIV, Starting HIV Treatment and Medical Care, HIV, Discrimination, and Law, HIV Case Management and Social Work, HIV Basic Science and Pathogenesis, HIV/AIDS Statistics, HIV and Mental Health Care, HIV Treatment and Medical Care, Women, Managing HIV Drug Resistance, HIV Advocacy and Activism, Disclosing Your HIV Status, HIV Drugs In Development, HIV Community Events, Mental Health, Living Well With HIV, Nevirapine (Viramune), First-Line HIV Treatment, Vaccines and Microbicides for HIV, Other Populations, Gay Men, Stavudine (d4T, Zerit), Conceiving and Having a Baby, Spirituality and Religion, HIV in Film, TV, and Media, HIV in Arts and Entertainment, HIV Stigma and Discrimination, People Under 30, Ritonavir (Norvir), HIV Risks and Symptoms, PEP (HIV Post-Exposure Prophylaxis), Zidovudine (AZT, Retrovir), Nutrition and Fitness, Non-Medical HIV Prevention, HIV in Books and Publishing, Understanding HIV-Related Lab Tests, PrEP (HIV Pre-Exposure Prophylaxis), Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada), Non-HIV Sexually Transmitted Infections, Tenofovir Disoproxil Fumarate (Viread), Myths About HIV/AIDS, Managing HIV Drug Resistance, Physical Health Issues, Kaletra (Lopinavir/Ritonavir), FDA-Approved HIV Medications, Latinx People, African-Americans, Raltegravir (Isentress), HIV/AIDS Basics, HIV in the Arts, Switching or Stopping HIV Treatment, Tuberculosis and HIV, History of HIV/AIDS, HIV Advocates in the Spotlight, Maraviroc (Selzentry, Celsentri), Managing Long-Term HIV Survivors, Lopinavir/Ritonavir (Kaletra), Lamivudine (3TC, Epivir), Stribild (Elvitegravir/Cobicistat/FTC/Tenofovir), Atazanavir (Reyataz), PrEP (HIV Pre-Exposure Prophylaxis), Emtricitabine (FTC, Emtriva), Enfuvirtide (T-20, Fuzeon), Curing HIV, Videx (Didanosine, ddI), HIV Prevention In Health Care Settings, People Over 50, PEP (HIV Post-Exposure Prophylaxis), Relationships and Sex, Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (Atripla), Efavirenz (Sustiva, Stocrin), Combivir (AZT/3TC), Intelence (Etravirine, TMC125), Viread (Tenofovir Disoproxil Fumarate)
The number of people who inject drugs has soared, yet many drug patients are not checked for the virus that can damage the liver.
If patients return to Dr. Crystal Bowe soon after taking medication for a sexually transmitted infection, she usually knows the reason: Their partners have re-infected them.
As rates of sexually transmitted diseases surge, public health officials want physicians to step up screening and treatment of patients.
A report on HIV patients is one example showing that though the state is often a national beacon in health care, some of its innovations fall short of expectations.
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C can't get the expensive drugs they need to cure it.
When the hepatitis C treatment Harvoni was released in 2014, Dr. Ronald Cirillo knew it was a big deal. "It's the reason that dragged me out of retirement!" he said.
The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.
With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic have a better chance at a cure.
Donor government funding to support HIV efforts in low- and middle-income countries fell for the first time in five years in 2015, decreasing from US$8.6 billion in 2014 to US$7.5 billion, finds a new report from the Kaiser Family Foundation and UNAI...
Needle exchanges could receive a financial boost this year following a decision by Congress to lift a ban on federal funding. As abuse of prescription drugs and opiates continues to spread across the nation, more states are considering exchanges as a...